Table 3.
Demographic and health characteristics of adults with confirmed SARS-CoV-2 infection (SDE database)
| No ID | ID | p value | |
|---|---|---|---|
| N in the analysis dataset | 8408930 | 45820 | |
| Age at covid-19 (median [IQR]) | 41.79 [29.95, 54.99] | 40.79 [27.99, 57.81] | < 0.001 |
| Female (%) | 54.0 | 42.2 | < 0.001 |
| Ethnicity (%) | < 0.001 | ||
| White | 82.8 | 87.7 | |
| Asian | 9.2 | 6.5 | |
| Black | 3.7 | 3.1 | |
| Mixed | 1.9 | 1.6 | |
| Other | 2.4 | 1.0 | |
| IMD decile (mean (SD)) | 5.36 (2.85) | 4.59 (2.74) | < 0.001 |
| Percent vaccinated at least once | 50.8 | 43.3 | < 0.001 |
| Vaccine, if any: (%) | < 0.001 | ||
| AstraZeneca | 41.4 | 58.7 | |
| Moderna | 6.6 | 2.9 | |
| Pfizer | 51.9 | 38.4 | |
| Percent affected by multimorbidity* | 13.1 | 32.4 | < 0.001 |
| Count of Long-Term Conditions (mean (SD))** | 1.32 (3.18) | 2.60 (4.20) | < 0.001 |
| Percent affected by polypharmacy*** | 20.9 | 55.6 | < 0.001 |
| Count of prescription medications (mean (SD)) | 2.70 (3.84) | 6.28 (5.07) | < 0.001 |
Note: p-values were obtained using t-tests for continuous variables (ones with a mean and SD presented) and Chi-squared tests for all other variables
*Multimorbidity: 3 + LTCs (including ID) of which at least one is physical [10]
**The count did not include ID
***5 + prescription medications